BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36897992)

  • 1. Clinical Features, Long-Term Outcomes, and Prognostic Factors of Eales' Disease in Korean Patients.
    Lee SM; Jung JH; Lee J; Choi EY; Shin JY; Kim M
    Ocul Immunol Inflamm; 2023 Mar; ():1-7. PubMed ID: 36897992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further evidence of the association of latent Mycobacterium tuberculosis in Eales' disease.
    Gupta P; Biswas J
    Int Ophthalmol; 2021 Mar; 41(3):901-906. PubMed ID: 33200391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of high-resolution computerized tomography chest in identifying tubercular etiology in patients diagnosed as Eales' disease.
    Kharel Sitaula R; Iyer V; Noronha V; Dutta Majumder P; Biswas J
    J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):4. PubMed ID: 28101723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eales' disease: epidemiology, diagnostic and therapeutic concepts.
    Murillo López S; Medina Medina S; Murillo López F
    Int J Retina Vitreous; 2022 Jan; 8(1):3. PubMed ID: 34983678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
    Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
    Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes of minimally invasive vitrectomy surgery in Eales' disease.
    Khanduja S; Gupta S; Sinha S; Venkatesh P; Vohra R; Garg S
    Nepal J Ophthalmol; 2013; 5(2):182-9. PubMed ID: 24172552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full panretinal photocoagulation and early vitrectomy improve prognosis of retinal vasculitis associated with tuberculoprotein hypersensitivity (Eales' disease).
    El-Asrar AM; Al-Kharashi SA
    Br J Ophthalmol; 2002 Nov; 86(11):1248-51. PubMed ID: 12386081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eales' disease in Inuit: report of four cases.
    Moldow B; la Cour M
    Acta Ophthalmol Scand; 2003 Jun; 81(3):304-8. PubMed ID: 12780413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eales' disease: increased oxidation and peroxidation products of membrane constituents chiefly lipids and decreased antioxidant enzymes and reduced glutathione in vitreous.
    Sulochana KN; Biswas J; Ramakrishnan S
    Curr Eye Res; 1999 Sep; 19(3):254-9. PubMed ID: 10487964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Eales' Disease and
    Bae K; Alcantara CA; Kim J; Tsui C; Venketaraman V
    Biology (Basel); 2024 Jun; 13(6):. PubMed ID: 38927340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.
    Alfayyadh MA; Alabdulhadi HA; Almubarak MH
    Cureus; 2021 Sep; 13(9):e18302. PubMed ID: 34722077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes for vitrectomy in Eales' disease.
    Shukla D; Kanungo S; Prasad NM; Kim R
    Eye (Lond); 2008 Jul; 22(7):900-4. PubMed ID: 17401324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term follow-up of Eales' disease.
    Atmaca LS; Batioglu F; Atmaca Sonmez P
    Ocul Immunol Inflamm; 2002 Sep; 10(3):213-21. PubMed ID: 12789597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New classification system-based visual outcome in Eales' disease.
    Saxena S; Kumar D
    Indian J Ophthalmol; 2007; 55(4):267-9. PubMed ID: 17595474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of epiretinal membranes associated with Eales' disease: a clinicopathologic evaluation.
    Majji AB; Vemuganti GK; Shah VA; Singh S; Das T; Jalali S
    Eye (Lond); 2006 Jan; 20(1):46-54. PubMed ID: 15877102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of a Large Cohort of Patients with Eales' Disease.
    Biswas J; K R R; Pal B; Gondhale HP; Kharel Sitaula R
    Ocul Immunol Inflamm; 2018; 26(6):870-876. PubMed ID: 28448727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales' disease.
    Kumar A; Sehra SV; Thirumalesh MB; Gogia V
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):685-90. PubMed ID: 22169980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further investigations on the association of Mycobacterium tuberculosis with Eales' disease.
    Madhavan HN; Therese KL; Doraiswamy K
    Indian J Ophthalmol; 2002 Mar; 50(1):35-9. PubMed ID: 12090085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eales' disease--10 years experience with a rare disease].
    Stoffelns BM; Kramann C; Schoepfer K
    Klin Monbl Augenheilkd; 2009 Apr; 226(4):299-304. PubMed ID: 19384787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of laser photocoagulation and/or vitrectomy in Eales' disease.
    Dehghan MH; Ahmadieh H; Soheilian M; Azarmina M; Mashayekhi A; Naghibozakerin J
    Eur J Ophthalmol; 2005; 15(3):379-83. PubMed ID: 15945008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.